Keynote Speakers
Walter Koch
Vice President, Roche Molecular Systems | 
Lawrence Rajendran
Velux Stiftung Professor for Systems and Cell Biology of Neurodegeneration, University of Zurich | 
Chamindie Punyadeera
Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology | .png)
Nicholas Dracopoli
Vice President/Head, Johnson & Johnson | 
Shana Kelley
Professor, University of Toronto | 
Minetta Liu
Associate Professor and Chair, Oncology Research, Mayo Clinic |
|
Lynn Sorbara
Program Director, National Cancer Institute | 
David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles | 
Hsian-Rong Tseng
Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles | 
Oscar Puig
Biomarker Leader, Hoffmann La Roche | 
Kendall Van Keuren-Jensen
Professor and Deputy Director, Translational Genomics Research Institute | 
Xandra Breakefield
Professor, Mass General Hospital (MGH)/Harvard Medical School | 
Ranjan Perera
Associate Professor, Scientific Director Genomics and Bioinformatics, Sanford Burnham Medical Research Institute | 
Frank Slack
Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School | 
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands | 
Raghu Kalluri
Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center | 
Ellen Beasley
Senior Vice President, Genomic Health Inc | 
Maximilian Diehn
Assistant Professor, Stanford University School of Medicine |
Overview
|
The 2nd Annual Biofluid Biopsies and High Value Diagnostics 2015 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby Circulating Biomarkers of various classes are being evaluated for their potential to be developed into diagnostics for cancer as well as other disease classes.
|
|
The Biofluid Biopsies Conference Track focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field. The High-Value Diagnostics Conference Track explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for patient monitoring and precision/targeted medicine. We also explore the front-end sample preparation challenges and approaches for the deployment of various biofluid classes ( plasma, serum, urine, cerebrospinal fluid, ovarian follicular fluid, and saliva) into diagnostics development in both the conference tracks. All conference delegates receive access to both concurrent, co-located conference tracks enabling maximal learning and maximizing networking opportunities. The two tracks are intertwined and presentations from the two tracks en bloc provide a complete picture of the liquid biopsy space as it currently exists. Present Your Research at this Conference in a Poster to a Worldwide Audience. Poster Submission Deadline: November 2, 2015.
Agenda and Information for:
|
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2015-11-16 00:00:002015-11-17 00:00:00Europe/LondonBiofluid Biopsies and High-Value Diagnostics 2015Biofluid Biopsies and High-Value Diagnostics 2015 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
Liquid Biopsy Slide Deck
.png)
